18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Clinical trial NCT00103649 · COMPLETED

Trial details

NCT number: NCT00103649
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2003-11-01
Primary completion: 2007-10-01
Enrollment: 1306

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.